Afeltra A - Search Results

1

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review.

Margiotta DPE, Basta F, Batani V, Afeltra A. Margiotta DPE, et al. Among authors: afeltra a. BMC Nephrol. 2018 Mar 7;19(1):54. doi: 10.1186/s12882-018-0847-z. BMC Nephrol. 2018. PMID: 29514612 Free PMC article. Review.

2

Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors.

Vadacca M, Margiotta D, Rigon A, Cacciapaglia F, Coppolino G, Amoroso A, Afeltra A. Vadacca M, et al. Among authors: afeltra a. J Rheumatol. 2009 Feb;36(2):295-7. doi: 10.3899/jrheum.080503. J Rheumatol. 2009. PMID: 19132788

3

The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study.

Afeltra A, Gigante A, Margiotta DP, Taffon C, Cianci R, Barbano B, Liberatori M, Amoroso A, Rossi Fanelli F. Afeltra A, et al. Intern Emerg Med. 2015 Sep;10(6):677-83. doi: 10.1007/s11739-015-1212-x. Epub 2015 Feb 27. Intern Emerg Med. 2015. PMID: 25720575

4

Polyunsaturated fatty acids: any role in rheumatoid arthritis?

Navarini L, Afeltra A, Gallo Afflitto G, Margiotta DPE. Navarini L, et al. Among authors: afeltra a. Lipids Health Dis. 2017 Oct 10;16(1):197. doi: 10.1186/s12944-017-0586-3. Lipids Health Dis. 2017. PMID: 29017507 Free PMC article. Review.

5

The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus.

Margiotta DPE, Basta F, Dolcini G, Batani V, Navarini L, Afeltra A. Margiotta DPE, et al. Among authors: afeltra a. PLoS One. 2017 Nov 7;12(11):e0187645. doi: 10.1371/journal.pone.0187645. eCollection 2017. PLoS One. 2017. PMID: 29112985 Free PMC article.

6

Fatigue in systemic sclerosis: a systematic review.

Basta F, Afeltra A, Margiotta DPE. Basta F, et al. Among authors: afeltra a. Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):150-160. Epub 2017 Dec 15. Clin Exp Rheumatol. 2018. PMID: 29303706 Free article.

7

Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus.

Margiotta DPE, Basta F, Dolcini G, Batani V, Lo Vullo M, Vernuccio A, Navarini L, Afeltra A. Margiotta DPE, et al. Among authors: afeltra a. PLoS One. 2018 Mar 5;13(3):e0193728. doi: 10.1371/journal.pone.0193728. eCollection 2018. PLoS One. 2018. PMID: 29505598 Free PMC article.

8

Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism.

Navarini L, Bisogno T, Mozetic P, Piscitelli F, Margiotta DPE, Basta F, Afeltra A, Maccarrone M. Navarini L, et al. Among authors: afeltra a. Int J Biochem Cell Biol. 2018 Jun;99:161-168. doi: 10.1016/j.biocel.2018.04.010. Epub 2018 Apr 12. Int J Biochem Cell Biol. 2018. PMID: 29655919

9

Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Fasano S, Margiotta DPE, Pierro L, Navarini L, Riccardi A, Afeltra A, Valentini G. Fasano S, et al. Among authors: afeltra a. Clin Rheumatol. 2019 Feb;38(2):457-463. doi: 10.1007/s10067-018-4286-9. Epub 2018 Sep 7. Clin Rheumatol. 2019. PMID: 30194649

10

Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results.

Navarini L, Bisogno T, Margiotta DPE, Piccoli A, Angeletti S, Laudisio A, Ciccozzi M, Afeltra A, Maccarrone M. Navarini L, et al. Among authors: afeltra a. J Immunol Res. 2018 Oct 21;2018:5264195. doi: 10.1155/2018/5264195. eCollection 2018. J Immunol Res. 2018. PMID: 30420970 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters